Written by Mainly looking for companies that can grow earnings per share for a long period of time. I generally have a… Summary Edwards Lifesciences is a high quality business by any and all measures. Edwards has an excellent financial profile, a history of organic growth as opposed to growth via M&A, and a history of returning cash to shareholders via share repurchases. Now that the earnings multiple for the stock is more reasonable, I believe investors could potentially achieve a 12.5% IRR over the next 5 years with an investment today. The biggest risk to this forecast is the hospital staffing shortage issue. I discuss why I think Edwards can grow despite this. I will also compare Edwards to Adobe. Both have similar margin profiles and expected growth rates, so think this exercise is constructive to show just how high quality of a business Edwards is. ipopba Edwards Lifesciences Corp (NYSE: EW ) is a proven, high quality business with long-term tailwinds. Despite this, the stock is down about 40% from its peak in early 2022. This drop can be attributed to short-term growth concerns and subsequent multiple compression. These short-term concerns are not unwarranted; growth has declined […]
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
